Echinacea Angustifolia, Hamammelis Virginiana, Calcarea Phosphorica, Hydrastis Canadanesis, Senega Officinalis, Silicea, Conium, Aurum Muriaticum Natronatum, Calcarea Carbonica, Fucus Vesiculosus, Lachesis Mutus 60295-0101
Product NDC
60295-0101- Manufacturer
- Nestmann Pharma Gmbh
- Dosage Form
- Tablet, Orally Disintegrating
- Product Type
- Drug For Further Processing
- Marketing Start
- March 1, 1992
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Conium Maculatum Flowering Top | 4 [hp_X]/1 |
| Echinacea Angustifolia | 1 [hp_X]/1 |
| Fucus Vesiculosus | 5 [hp_X]/1 |
| Goldenseal | 4 [hp_X]/1 |
| Hamamelis Virginiana Root Bark/stem Bark | 2 [hp_X]/1 |
| Lachesis Muta Venom | 8 [hp_X]/1 |
| Oyster Shell Calcium Carbonate, Crude | 5 [hp_X]/1 |
| Polygala Senega Root | 4 [hp_X]/1 |
| Silicon Dioxide | 4 [hp_X]/1 |
| Sodium Tetrachloroaurate | 5 [hp_X]/1 |
| Tribasic Calcium Phosphate | 3 [hp_X]/1 |
Packaging Options(1)
25000 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER (60295-0101-3)